Cellular localization of the activated EGFR determines its effect on cell growth in MDA-MB-468 cells

Experimental Cell Research

Volumn 314, Issue 18, 2008, Pages 3415-3425

  Hyatt, Dustin C ^a   Ceresa, Brian P ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Caspase 3; EGFR; Endocytosis

Indexed keywords

CASPASE 3; EPIDERMAL GROWTH FACTOR RECEPTOR; POLYSTYRENE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL FUNCTION; CELL GROWTH; CELL MEMBRANE; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

EID: 54249140899     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.08.020     Document Type: Article

References (51)

1. Olayioye M.A., Neve R.M., Lane H.A., and Hynes N.E. The ErbB signaling network: Receptor heterodimerization in development and cancer. EMBO J. 19 (2000) 3159-3167
2. Yarden Y., and Sliwkowski M.X. Untangling the ErbB signalling network. Nat. Rev., Mol. Cell Biol. 2 (2001) 127-137
3. Sorkin A., and Waters C.M. Endocytosis of growth factor receptors. BioEssays 15 (1993) 375-382
4. Wiley H.S., and Burke P.M. Regulation of receptor tyrosine kinase signaling by endocytic trafficking. Traffic 2 (2001) 557-564
5. Burke P., Schooler K., and Wiley H.S. Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. Mol. Biol. Cell 12 (2001) 1897-1910
6. DiGuglielmo G.M., Baass P.C., Ou W.J., Posner B.I., and Bergeron J.J. Compartmentalization of Shc, Grb2 and mSOS, and hyperphosphorylation of raf-1 by EGF but not insulin in liver parenchyma. EMBO J. 13 (1994) 4269-4277
7. Ceresa B.P., and Schmid S.L. Regulation of signal transduction by endocytosis. Curr. Opin. Cell Biol. 12 (2000) 204-210
8. Sorkin A., and von Zastrow M. Signal transduction and endocytosis: close encounters of many kinds. Nat. Cell Biol. Rev. 3 (2002) 600-614
9. Dinneen J.L., and Ceresa B.P. Constitutive activation of rab5 results in a ligand independent redistribution of the EGFR and attenuates its ability to signal. Traffic 5 (2004) 606-615
10. Huang F., Khvorova A., Marshall W., and Sorkin A. Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference. J. Biol. Chem. 279 (2004) 16657-16661
11. Ringerike T., Stang E., Johanessen L.E., Sandnes D., Levy F.O., and Madshus I.H. High-affinity binding of epidermal growth factor (EGF) to EGF receptor is disrupted by overexpression of mutant dynamin (K44A). J. Biol. Chem. 273 (1998) 16639-16642
12. Carpentier J.L., Sawano A., Geiger D., Gorden P., Perrelet A., and Orci L. Potassium depletion and hypertonic medium reduce "non-coated" and clathrin-coated pit formation, as well as endocytosis through these two gates. J. Cell. Physiol. 138 (1989) 519-526
13. King A.C. Monensin, like methylamine, prevents degradation of 125I-epidermal growth factor, causes intracellular accumulation of receptors and blocks the mitogenic response. Biochem. Biophys. Res. Commun. 124 (1984) 585-591
14. Armstrong D.K., Kaufmann S.H., Ottaviano Y.L., Furuya Y., Buckley J.A., Isaacs J.T., and Davidson N.E. Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res. 54 (1994) 5280-5283
15. Gill G.N., and Lazar C.S. Increase phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells. Nature 293 (1981) 305-307
16. Kottke T.J., Blajeski A.L., Martins L.M., Mesner Jr. P.W., Davidson N.E., Earnshaw W.C., Armstrong D.K., and Kaufmann S.H. Comparison of paclitaxel-, 5-Fluoro-2′-deoxyuridine-, and epidermal growth factor (EGF)-induced apoptosis. J. Biol. Chem. 274 (1999) 15927-15936
17. Reynolds A.R., Tischer C., Verveer P.J., Rocks O., and Bastiaens P.I.H. EGFR Activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation. Nat. Cell Biol. 5 (2003) 447-453
18. Ceresa B.P., Kao A.W., Santeler S.R., and Pessin J.E. Regulation of insulin receptor signaling pathways by clathrin mediated endocytosis. Mol. Cell. Biol. 18 (1998) 3862-3870
19. Ceresa B.P., Lotscher M., and Schmid S.L. Receptor and membrane recycling occur with unaltered kinetics despite dramatic rab5(Q79L)-induced changes in endosome geometry. J. Biol. Chem. 276 (2001) 9649-9654
20. Sorkin A.D., Teskenko L.V., and Nikolsky N.N. The endocytosis of epidermal growth factor in A431 cells: a pH of microenvironment and the dynamics of receptor complex dissociation. Exp. Cell Res. 175 (1988) 192-205
21. Waters C.M., Oberg K.C., Carpenter G., and Overholser K. Rate constants for binding, dissociation, and internalization of EGF: effect of receptor occupancy and ligand concentration. Biochemist 29 (1990) 3563-3569
22. Schaerli P., and Jaggi R. EGF-induced programmed cell death of human mammary carcinoma MDA-MB-468 cells is preceded by activation of AP-1. Cell. Mol. Life Sci. 54 (1998) 129-138
23. Hansen M.B., Nielsen S.E., and Berg K. Re-examination and further development of a precise method for measuring cell growth/cell kill. J. Immunol. Methods 119 (1989) 203-210
24. Filmus J., Pollak M.N., Cailleau R., and Buick R.N. MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem. Biophys. Res. Commun. 128 (1985) 898-905
25. Krupp M., Connolly D., and Lane M. Synthesis, turnover, and down-regulation of epidermal growth factor receptors in human A431 epidermoid carcinoma cells and skin fibroblasts. J. Biol. Chem. 257 (1982) 11489-11496
26. French A.R., Sudlow G.P., Wiley H.S., and Lauffenburger D.A. Postendocytic trafficking of epidermal growth factor-receptor complexes is mediated through saturable and specific endosomal interactions. J. Biol. Chem. 269 (1994) 15749-15755
27. Stoscheck C.M., and Carpenter G. Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts. J. Cell Biol. 98 (1984) 1048-1053
28. Dinneen J.L., and Ceresa B.P. Expression of dominant negative rab5 in HeLa cells regulates EGFR endocytic trafficking distal from the plasma membrane. Exp. Cell. Res. 294 (2004) 509-522
29. Verveer P.J., Wouters F.S., Reynolds A.R., and Bastiaens P.I.H. Quantitative imaging of lateral ErbB1 receptor signal propagation in the plasma membrane. Science 290 (2000) 1567-1570
30. Kempiak S.J., Yip S.C., Backer J.M., and Segall J.E. Local signaling by the EGF receptor. J. Cell Biol. 162 (2003) 781-787
31. Guilli L.F., Palmer K.C., Chen Y.Q., and Reddy K.B. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity. Cell Growth Differ. 7 (1996) 173-178
32. Masui H., Castro L., and Mendelsohn J. Consumption of EGF by A431 cells: evidence for receptor recycling. J. Cell Biol. 120 (1993) 85-93
33. Holbro T., Civenni G., and Hynes N.E. The ErbB receptors and their role in cancer progression. Exp. Cell Res. 284 (2003) 99-110
34. Fan V.H., Tamama K., Au A., Littrell R., Richardson L.B., Wright J.W., Wells A., and Griffith L.G. Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells 25 (2007) 1241-1251
35. Ito Y., Li J.S., Takahashi T., Imanishi Y., Okabayashi Y., Kido Y., and Kasuga M. Enhancement of the mitogenic effect by artificial juxtacrine stimulation using immobilized EGF. J. Biochem. 121 (1997) 514-520
36. Wiley H.S. Anomalous binding of epidermal growth factor to A431 cells is due to the effect of high receptor densities and a saturable endocytic system. J. Cell Biol. 1-7 (1988) 801-810
37. Schneider-Brachert W., Tchikov V., Neumeyer J., Jakob M., Winoto-Morback S., Held-Feindt J., Heinrich M., Merkel O., Ehrenschwender M., Adam D., Mentlein R., Kabelitz D., and Schutze S. Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21 (2004) 415-428
38. Stern D.F. Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases. Breast Cancer Res. 2 (2000) 176-183
39. Lotti L.V., Di Lazzaro C., Zompetta C., Frati L., and Torrisi M.R. Surface distribution and internalization of erbB-2 proteins. Exp. Cell Res. 202 (1992) 274-280
40. Hurwitz E., Stancovski I., Sela M., and Yarden Y. Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake. Proc. Natl. Acad. Sci. 92 (1995) 3353-3357
41. Singh A.B., Tsukada T., Zent R., and Harris R.C. Membrane-associated HB-EGF modulates HGF-induced cellular responses in MDCK cells. J. Cell. Sci. 117 (2004) 1365-1379
42. Singh A.B., Sugimoto K., and Harris R.C. Juxtacrine activation of epidermal growth factor (EGF) receptor by membrane-anchored heparin-binding EGF-like growth factor protects cells from anoikis while maintaining an epithelial phenotype. J. Biol. Chem. 282 (2007) 32890-32901
43. Engelman J.A., Chu C., Lin A., Jo H., Ikezu T., Okamoto T., Kohtz D.S., and Lisanti M.P. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. FEBS Lett. 428 (1998) 205-211
44. Mineo C., Gill G.N., and Anderson R.G. Regulated migration of epidermal growth factor receptor from caveolae. J. Biol. Chem. 274 (1999) 30636-30643
45. Waugh M.G., Lawson D., and Hsuan J.J. Epidermal growth factor receptor activation is localized within low-bouyant density, non-caveolar membrane domains. Biochem. J. 337 (1999) 591-597
46. Lax I., Bellot F., Howk R., Ullrich A., Givol D., and Schlessinger J. Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules. EMBO J. 8 (1989) 421-427
47. Bellot F., Moolenaar W.H., Kris R., Mirakhur B., Verlaan I., Ullrich A., Schlessinger J., and Felder S. High-affinity epidermal growth factor binding is specifically reduced by a monoclonal antibody, and appears necessary for early responses. J. Cell Biol. 110 (1990) 491-502
48. Defize L.H.K., Boonstra J., Meisenhelder J., Kruijer W., Tertoolen L.G.J., Tilly B.C., Hunter T., van Bergen en Henegouwen P.M.P., Moolenaar W.H., and de Laat S.W. Signal transduction by epidermal growth factor occurs through the subclass of high affinity receptors. J. Cell Biol. 109 (1989) 2495-2507
49. Ullrich A., and Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 61 (1990) 203-212
50. Macdonald J.L., and Pike L.J. Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 112-117
51. Livneh E., Prywes R., Kashles O., Reiss N., Sasson I., Mory Y., Ullrich A., and Schlessinger J. Reconstitution of human epidermal growth factor receptors and its deletion mutants in cultured hamster cells. J. Biol. Chem. 261 (1986) 12490-12497